Stay updated with breaking news from Absci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Platinum Investment Management Ltd. increased its stake in Absci Co. (NASDAQ:ABSI – Free Report) by 124.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,306,668 shares of the company’s stock after buying an additional 725,144 shares during the quarter. […]
HC Wainwright reaffirmed their buy rating on shares of Absci (NASDAQ:ABSI – Free Report) in a report released on Wednesday morning, MarketBeat reports. The brokerage currently has a $4.00 price target on the stock. HC Wainwright also issued estimates for Absci’s Q4 2023 earnings at ($0.21) EPS, Q2 2024 earnings at ($0.17) EPS, Q3 2024 […]
Wealth Alliance Advisory Group LLC acquired a new stake in Absci Co. (NASDAQ:ABSI – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 28,240 shares of the company’s stock, valued at approximately $43,000. Other hedge funds and other institutional investors have also added to or […]
Absci, an AI-driven drug discovery company, laid off 30 employees, 15% of its staff, due to operational efficiencies. Stock is down 20% since 2021 IPO
Absci (NASDAQ:ABSI – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Truist Financial in a report released on Wednesday, Benzinga reports. They presently have a $10.00 target price on the stock. Separately, HC Wainwright restated a “buy” rating and set a $4.00 price target on shares of Absci in a […]